Stockreport

ImmunityBio shares fall on FDA warning letter over cancer therapy claims in ad [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF television advertisement ?and podcast promoting its cancer therapy were false or misleading and violated federal law. ImmunityBio's Anktiva was approved for a ?type of [Read more]